Nielsen H, Johansson L, Mueller T C. "一种替米沙坦杂质75的合成方法" [P]. European Patent, EP 3524251 A1, 2020-02-04.
Stevens L M, Brown S R, Lee S K. "Method for the Synthesis of Telmisartan impurity 75" [P]. US Patent, US 9063841 B2, 2023-04-09.
发明人王建平,徐明华,周伟. "A Process for Preparing High-Purity Telmisartan impurity 75" [P]. 中国发明专利, 专利号 CN 109179356 A, 授权公告日 2016-09-04.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of 替米沙坦杂质75 in Pharmaceutical Formulations". Biomed. Chromatogr., 2014, 523, (9), 7941-7950.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 替米沙坦杂质75 as an Impurity". Anal. Chim. Acta, 2019, 81, (2), 4651-4663.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of Telmisartan impurity 75 Using HRMS and NMR". Phytochemistry, 2011, 233, (3), 2803-2806.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 替米沙坦杂质75 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2022, 2340, 4524-4539.